Neurological Disorders

Tourette syndrome drug pipeline

  • ICD-11 8A05.00
  • MeSH D005879

2 compounds from 2 companies are in active clinical development for tourette syndrome, including 1 at Phase 3 or beyond.

2Compounds
2Companies
1Phase 3+
5Trials recruiting
  • Filed (NDA) 1
  • Phase 2 1

Mechanisms: Small molecule (1) · Neuroactive Steroid (1)

Pipeline data compiled July 2026 · every fact sourced.

Upcoming readouts & recent results

  • 2026-06-18ReportedEcopipamRegulatory

    Teva submitted the U.S. NDA for ecopipam in pediatric Tourette syndrome (guided for 2H 2026; submitted 2026-06-18).

  • 2026-05-26ReportedEcopipamTopline datametNCT05615220

    D1AMOND Phase 3 met primary and secondary endpoints: ecopipam delayed time to relapse vs placebo in pediatric (HR=0.5, p=0.0084) and combined (HR=0.5, p=0.0050) Tourette populations; published in JAMA Neurology.

  • 2023-04-01ReportedSepranoloneTopline datamixedNCT05434546

    Sepranolone Phase 2a in Tourette syndrome: 28% YGTSS tic reduction vs 12.6% control (p=0.051); all secondary endpoints (PUTS, GTS-QOL, impairment) favored sepranolone; favorable safety.

See the full catalyst calendar →

Compounds in development (2)

CompoundCompanyPhaseStatusMechanism
EcopipamOrphanFast TrackTeva Pharmaceutical Industries Ltd.Filed (NDA)ActiveD1 receptor Antagonist
SepranoloneRelmada Therapeutics, Inc.Phase 2CompletedGABA-A receptor Antagonist

Trials recruiting now (4)

4 drug-interventional tourette syndrome trials recruiting now, of 78 registered interventional trials. Browse all on ClinicalTrials.gov →

Frequently asked

How many drugs are in development for tourette syndrome?
2 compounds from 2 companies are in active clinical development for tourette syndrome, including 1 at Phase 3 or beyond.
Which tourette syndrome drugs are in Phase 3?
Phase 3 (or later) programs for tourette syndrome include Ecopipam.
How many clinical trials are recruiting for tourette syndrome?
4 drug-interventional tourette syndrome trials are currently recruiting participants, out of 78 registered interventional trials.